Basics Kodiak Sciences Inc IPO Date: October 1, 2018 Sector: Healthcare Industry: Biotech Market Cap: $433.19M Activated in VL: True Average Daily Range Avg Daily Range: $1.06 | 3.70% Avg Daily Range (30 D): $0.41 | 6.80% Avg Daily Range (90 D): $0.25 | 5.66% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 1,213 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.83M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.82M Avg Closing Trade (30 D): $.71M Avg Closing Trade (90 D): $.85M Avg Closing Volume: 59.28K     News Jan 10, 2025 @ 2:35 PM Diabetic Retinopathy Global Clinical Trials Review... Source: Researchandmarkets.Com Jun 20, 2024 @ 12:23 PM Should You Hold Kodiak Sciences (KOD) Stock in You... Source: Zacks Equity Research Jun 14, 2024 @ 3:30 PM Why Is Kodiak Sciences (KOD) Down 26.2% Since Last... Source: Zacks Equity Research May 16, 2024 @ 4:51 PM Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipel... Source: Zacks Equity Research Apr 4, 2024 @ 4:09 PM Kodiak (KOD) Counts on Tarcocimab Program Despite ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.63 $-1.09 $-.84 Diluted EPS $-3.63 $-1.09 $-.84 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -190.63M $ -57.46M $ -44.11M Operating Income / Loss $ -199.87M $ -59.07M $ -46.18M Cost of Revenue $ $ $ Net Cash Flow $ -107.07M $ -29.22M $ -29.79M PE Ratio